Chemical Structure : Radotinib
CAS No.: 926037-48-1
Catalog No.: PC-38025Not For Human Use, Lab Use Only.
Radotinib (IY-5511) is a potent and selective BCR-ABL1 tyrosine kinase inhibitor with IC50 of 34 nM for wild-type BCR-ABL1 kinase.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $58 | In stock | |
25 mg | $98 | In stock | |
100 mg | $248 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Radotinib (IY-5511) is a potent and selective BCR-ABL1 tyrosine kinase inhibitor with IC50 of 34 nM for wild-type BCR-ABL1 kinase.
Radotinib (IY-5511) displays high selectivity over c-kit (1,324 nM), PDGFR (PDGFRα, 75.5 nM; PDGFRβ, 130 nM) and src (>2,000 nM).
Radotinib (IY-5511) effectively inhibited the proliferation of common mutant clones of BCR-ABL1, with the exception of T315I.
M.Wt | 530.5 | |
Formula | C27H21F3N8O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzamide |
1. Kim SH, et al. Haematologica. 2014 Jul;99(7):1191-6.
2. Heo SK, et al. PLoS One. 2015 Jun 12;10(6):e0129853.
3. Kwak JY, et al. Clin Cancer Res. 2017 Dec 1;23(23):7180-7188.
4. Heo SK, et al. Sci Rep. 2017 Nov 10;7(1):15278.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright